Seeking Alpha

maven pharm

maven pharm
Send Message
View as an RSS Feed
View maven pharm's Comments BY TICKER:
Latest  |  Highest rated
  • Looking For Value Among Biotechs After Precipitous Declines In Stock Price [View article]
    achillion pharmaceuticals is of value for its in house research which competes with the best pharmaceutical companies like Gilead and Astra Zeneca. This company has so many research prospects. It is a diamond in the rough. It is a must buy in biotech. I imagine it will be significantly higher in 2 years.
    Mar 24 06:49 PM | Likes Like |Link to Comment
  • Caremark And Walgreen - 2 Worthy Investments [View article]
    Both cvs and walgreen lose alot of front end business because for many items people do far better buying some items at dollar stores and box stores ie Target, Walmart. Also insurance companies have lowered profit margins that are being paid per prescription. So Walgreen and CVS lose there. But long term both companies seem to offer excellent growth prospects; CVS more than Walgreen.
    Mar 21 12:51 PM | Likes Like |Link to Comment
  • Chimerix: A Company Focused On Infectious Viral Diseases With Investment Characteristics Similar To Trius [View article]
    What is most interesting about Chimerix is that the drug is active against a number of virus in the herpes family and other viruses. I guess that means that the drug may have numerous other indications against a number of diseases.It looks llike there might be some volatility in the stock but the potential is there. It looks like someone who is willing to make a long term commitment to owning this stock will be rewarded .
    Mar 17 11:36 PM | Likes Like |Link to Comment
  • AVEO Pharmaceuticals EPS in-line. [View news story]
    Something is very strange about the FDA rejection of AVEO pharmaceutical drug.
    It appeared like it benefited patients and its effectiveness was similar to other drugs
    approved on market and yet FDA refused them. Strange.
    Mar 13 11:05 PM | Likes Like |Link to Comment
  • Buffett: PepsiCo doesn't need to split business up [View news story]
    Yeah Pepsi would be able to keep the beverage business if it was being run properly. But management is deficient. They bought Quaker Oats and took a company that was very profitable and with tremendous growth potential and made it just an ordinary company with limited potential. Management is deficient and the only way to shake up Pepsi is to break up its corporate structure by a spin off. It would be great for shareholders and the company. Separately the company would be worth over $100 a share. Please break up this company.
    Mar 3 11:36 AM | Likes Like |Link to Comment
  • Forthcoming Clinical Trial Results Could Push Prana Shares Even Higher [View article]
    It is a tough call. My feeling is that it will go higher based on the sensation of a drug for Alzheimer; whether it works or not. But I have a feeling; it will be effective and this stock will

    roar higher and higher. It is a winner.
    Jan 31 12:48 AM | 1 Like Like |Link to Comment
  • Eli Lilly: 2014 Predictions [View article]
    Lilly at this price is a great deal. I will tell you why. Insulin use is a growth industry. Many people have diabetes and do not know it. With the national health care program in place; many more people will be taking insulin. Lilly is big in insulin but what held them back was competition from Novo-Nordisk and Sanofi who had long acted insulins that doctors liked. But now with a new insulin coming from Lilly that competes with Lantus; things will change in Lilly's favor.It has other drugs coming out. It also sports a good dividend and they have the Alzheimer drug which if gains approval will give the company megabucks. I say bank on Lilly and it will reward you handsomely,
    Jan 28 09:31 AM | 3 Likes Like |Link to Comment
  • Idenix falls hard in response to JMP downgrade [View news story]
    I do not care what JCP Securities thinks. These companies have a faulty way of evaluating

    new pharmaceutical research. Idenix is a diamond in pharmaceutical research and this will be identified by a much higher price in this security in 6 months. It might remain a stand alone company or it is possible an international pharmaceutical company will see its true value and acquire it.
    Jan 27 02:36 PM | Likes Like |Link to Comment
  • Idenix falls hard in response to JMP downgrade [View news story]
    ,,,,,
    Jan 27 02:31 PM | Likes Like |Link to Comment
  • Rite Aid: Long Term Appeal As Earnings Improvement Show Relative Undervaluation [View article]
    Rite Aid is an absolute bargain. It will improve his prescription count because of Obama Care and really $10 by spring is not out of the question. Buy this stock.
    Oct 20 01:31 PM | 2 Likes Like |Link to Comment
  • Don't Be So Fast To Buy The Dip In Lannett [View article]
    The Lannett company has raised their prices on some of their core products which are popular and used in chronic conditions. Meaning individuals of to take their medicine every day for years.
    It make generic Thyroid medication for hypothyroid conditions.
    It makes generic Lanoxin for congestive heart failure.
    It makes generic phenobarbital for epilepsy
    It makes migraine medications.
    The price of all these drugs have at least quadrupled in the market places and if these prices hold, Lannett has a windfall. A large pharmaceutical company might buy them out. If Obamacare kicks in their pharmaceutical sales will skyrocket and their profits along with it. So yeah Lannett was a sleeper but now it is moving up and may go up more.
    Oct 20 12:54 AM | Likes Like |Link to Comment
  • Merck - Little Appeal Despite Recently Announced Cost Cuts [View article]
    Merck is a gem. Just like all these multinationals pharmaceutical firms
    they can generate cash and profit either by new drugs, raises prices or cutting costs. Merck is a powerhouse. Buy Merck long term.
    Oct 15 03:19 PM | Likes Like |Link to Comment
  • Eli Lilly And Company - Jefferies Is Unnecessarily Bearish Amid Patent Expirations [View article]
    I would not worry about Eli Lilly;once Obama care kicks in and the federal plans are paying for insulin. Many people are diabetics and do not know it because they have no health care plans. Once all is in place the demand for insulin will increase and they probably will raise prices. Lilly has always found someone to survive. It is a good investment. Although the stock price may fluctuate and you can not beat these large pharmaceutical companies from their ingenuity in generated profit. Buy Eli Lilly especially if price drops.
    Oct 15 03:18 PM | 1 Like Like |Link to Comment
  • Follow These 6 People And Jump The J.C. Penney Ship [View article]
    It looks like J.C. Penney will go to $5.00 per share and stay there a long time. Part of the problem is many shoppers do not have to find a J.C. Penney department store when they can buy it at a Target or Walmart for less; especially if it is closer in to where they live. The only thing that can save J.C. Penney is to create Mini- Penneys, like the mini Wal-marts created. It would not carry all the regular merchandise but they could build them in cities close to where people live. A thought.
    Oct 8 01:03 PM | Likes Like |Link to Comment
  • Rite Aid: Long Term Appeal As Earnings Improvement Show Relative Undervaluation [View article]
    You know Rite Aid has about 4,500 stores but management seems weak compared to CVS and Walgreens. The potential is there but unless they are able to change management or improve techniques in store operations I stock may hang over 5-7 dollars this year. But my hunch is it will trade at $10 per share. I do not think CVS OR WALGREEN WOULD ACQUIRE THIS COMPANY. But what would make more sense would be for a company like Wal-Mart to acquire it; than they could make take each store and make Mini Walmarts all over the country and give the other Drug chains a run for their money. Walgreens and CVS would not be happy at all.
    Sep 23 10:21 PM | Likes Like |Link to Comment
COMMENTS STATS
114 Comments
39 Likes